© 2022 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
The antiviral drug is the first treatment for the new coronavirus to be approved in United States.
Nine key findings from a survey of HIV-positive people 50 and older. Plus: A special report on aging with HIV during COVID-19.
FDA grants emergency use authorization, but randomized clinical trials of the antiviral drug show mixed results.
As a result, researchers in Spain are testing whether HIV med Truvada, often used as PrEP, can also prevent COVID-19.
The assurance arrives as the pharma giant cuts off most emergency access to remdesivir, a potential COVID-19 treatment.
Gilead Sciences is giving its antiviral remdesivir to nearly 1,000 people as part of two clinical trials.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
